Workplace practices for engineered nanomaterial manufacturers

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 2, Issue 6, 2010, Pages 685-692

  Woskie, Susan ^a  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROL METHODS; ENGINEERED NANOMATERIALS; ENGINEERING CONTROLS; HEALTH AND SAFETY; NANOMATERIAL; NANOTOXICOLOGY; NASCENT FIELD; OCCUPATIONAL HEALTH AND SAFETY; PERSONAL PROTECTIVE EQUIPMENT; PRECAUTIONARY APPROACH; WORK PRACTICES; WORKPLACE PRACTICES;

EXPOSURE CONTROLS; HEALTH; HEALTH HAZARDS; INDUSTRIAL HYGIENE; MANUFACTURE; MATERIALS HANDLING; NANOSTRUCTURED MATERIALS; OCCUPATIONAL RISKS; PROTECTIVE CLOTHING;

HEALTH RISKS;

ENGINEERED NANOMATERIAL; NANOMATERIAL; NANOPARTICLE; POLYETHYLENE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; GOOD MANUFACTURING PRACTICE; HEALTH HAZARD; HUMAN; MATERIALS HANDLING; NANOENGINEERING; NANOFABRICATION; NANOTECHNOLOGY; NANOTOXICOLOGY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; OCCUPATIONAL SAFETY; PARTICLE SIZE; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; RISK ASSESSMENT; RISK MANAGEMENT; TRAINING; VENTILATOR; WORKPLACE; EDUCATION; REVIEW; RISK FACTOR; STANDARD;

EDUCATION; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PROTECTIVE DEVICES; RISK FACTORS; RISK MANAGEMENT; WORKPLACE;

EID: 79952202537     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.101     Document Type: Article

References (58)

1. Lux R. Nanomaterials State of the Market Q1 2009: Cleantech's Dollar Investments, Penny Returns; 2008. Available at: (updated 2008; cited 2009 December 15).
2. Woodrow Wilson C, Project on Emerging Nanotechnologies: Consumer Products Inventory; 2009. Available at: (updated 2009; cited 2009. December 15, 2009).
3. NNI, NNI Supplement to the Presidents 2010 budget; 2009. Available at: (updated 2009. cited 2009 December 15).
4. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113: 823-839.
5. Oberdorster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 1994, 102(Suppl 5): 173-179.
6. Zhang Q, Kusaka Y, Zhu X, Sato K, Mo Y, Kluz T, Donaldson K. Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J Occup Health 2003, 45: 23-30.
7. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 2001, 175: 191-199.
8. Duffin R, Tran L, Brown D, Stone V, Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 2007, 19: 849-856.
9. Dick CA, Brown DM, Donaldson K, Stone V. The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal Toxicol 2003, 15: 39-52.
10. 2 particles: differential responses related to surface properties. Toxicology 2007, 230: 90-104.
11. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, Stone V, Brown S, William MacNee W, Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nature Nanotechnol 2008, doi:10.1038/nnano.2008.111.
12. Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, Warheit DB, Colvin VL. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci 2006, 92: 174-185.
13. Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, Kitajima SJK. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 2008, 33: 105-116.
14. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004, 77: 126-134.
15. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005, 289: L698-L708.
16. Li Z, Hulderman T, Salmen R, Chapman R, Leonard SS, Young SH, Shvedova A, Luster MI, Simeonova PP. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect 2007, 115: 377-382.
17. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 2005, 146: 882-893.
18. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002, 65: 1531-1543.
19. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004, 16: 437-445.
20. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006, 114: 1172-1178.
21. Porter AE, Gass M, Muller K, Skepper JN, Midgley P, Welland M. Visualizing the uptake of C60 to the cytoplasm and nucleus of human monocyte-derived macrophage cells using energy-filtered transmission electron microscopy and electron tomography. Environ Sci Technol 2007, 41: 3012-3017.
22. Moller W, Brown DM, Kreyling WG, Stone V. Ultrafine particles cause cytoskeletal dysfunctions in macrophages: role of intracellular calcium. Part Fibre Toxicol 2005, 2: 7.
23. Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005, 155: 377-384.
24. Howard J, Murashov V. National nanotechnology partnership to protect workers. J Nanopart Res 2009, 11: 1673-1683.
25. Tomasco PJ. Manufactured nanomaterials: avoiding TSCA and OSHA violations for potentially hazardous substances. Boston Coll Environ Aff Law Rev 2006, 33: 205-45.
26. Bergeson LL, Plamond JE. TSCA and engineered nanoscale substances. Nanotechnol Law Bus 2007, 4: 617-640.
27. EPA. TSCA Inventroy Status of Nanoscale Substances-General Approach January 23, 2008. Available at: (updated 2008; cited 2010. April 20, 2010).
28. EPA, New Chemicals Program, 2010. Available at: (updated 2010; cited March 23, 2010).
29. EPA. Nanoscale Materials Stewardship Program: Interim report, 2009. Available at: (updated 2009; cited March 23, 2010).
30. EPA. Nanoscale Materials Stewardship Program, 2010. Available at: (updated 2010; cited March 23, 2010).
31. Nanowerk. 'Nanowerk database', 2010. Available at: (updated 2010; cited January 22, 2010).
32. UN. Report of the United Nations Conference on Environment and Development, Annex I, 1992. Available at: (updated 1992; cited December 15, 2009).
33. European Community. Communication from the Commission on the precautionary principle, 2000. Available at: (updated 2000; cited 2009. December 15).
34. Murashov V, Howard J. Essential features for proactive risk management. Nat Nanotechnol 2009, 4: 467-470.
35. Japanese LB. Precautionary measures to prevent expo- sure to nanomaterials at workplaces where they are produced or handled, 2008. Available at: (updated 2008; cited December 15, 2009).
36. Hansen SF, Maynard A, Baun A, Tickner JA. Late lessons from early warnings for nanotechnology. Nat Nanotechnol 2008, 3: 444-447.
37. Schulte PA, Salamanca-Buentello F. Ethical and scientific issues of nanotechnology in the workplace. Environ Health Perspect 2007, 115: 5-12.
38. Schulte P, Geraci C, Zumwalde R, Hoover M, Kuempel E. Occupational risk management of engineered nanoparticles. J Occup Environ Hyg 2008, 5: 239-249.
39. Paik SY, Zalk DM, Swuste P. Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures. Ann Occup Hyg 2008, 52: 419-428.
40. Conti JA, Killpack K, Gerritzen G, Huang L, Mircheva M, Delmas M, Harthorn BH, Appelbaum RP, Holden PA. Health and safety practices in the nanomaterials workplace: results from an international survey. Environ Sci Technol 2008, 42: 3155-3162.
41. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2005, 2: 8.
42. Brouwer DH, Gijsbers JH, Lurvink MW. Personal exposure to ultrafine particles in the workplace: exploring sampling techniques and strategies. Ann Occup Hyg 2004, 48: 439-453.
43. NIOSH. Approaches to Safe Nanotechnology: Managing the Health and Safety Concerns Associated with Engineered Nanomaterials. Report No.: 2009-125 Contract No.: Document Number; 2009.
44. Peters TM, Elzey S, Johnson R, Park H, Grassian VH, Maher T, O'Shaughnessy P. Airborne monitoring to distinguish engineered nanomaterials from incidental particles for environmental health and safety. J Occup Environ Hyg 2009, 6: 73-81.
45. OSHA OSaHA. Hazard Communication Standard(29 CFR) 1910.1200; 1994.
46. NIOSH. Current intelligence bulletin 60: interim guidance on medical screening of workers potentially exposed to engineered nanoparticles. Department of Health and Human Services CfDCaP. Cincinnati, OH: National Institute for Occupational Safety and Health; 2009.
47. Sayes CM, Fortner J, Guo W, Lyon D, Boyd A, Ausman K, Tao Y. The differential cytotoxicity of water-soluble fullerenes. Nano Letters 2004, 4: 1881-1887.
48. Sayes CM, Liang F, Hudson J, Mendez J, Guo W, Beach J, Moore V. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 2006, 161: 135-142.
49. A Survey of Current Practices in the Nanotech- nology Workplace: Phase 2. [database on the Inter- net]. Rice University, 2006. Available at: (cited 22 February 2009).
50. Tsai S, Ada E, Isaacs J, Ellenbecker MJ. Airborne nanoparticle exposures associated with the manual handling of nanoalumina in fume hoods. J Nanoparticle Res 2009, 11: 147-161.
51. Methner MM. Engineering case reports. Effectiveness of local exhaust ventilation (LEV) in controlling engineered nanomaterial emissions during reactor cleanout operations. J Occup Environ Hyg 2008, 5: D63-D69.
52. Kim S, Harrington MS, DYH P. Experimental study of nanoparticles penetration through commercial filter media. J Nanoparticle Res 2007, 9: 117-125.
53. Tinkle SS, Antonini JM, Rich BA, Roberts JR, Salmen R, DePree K, Adkins EJ. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 2003, 111: 1202-1208.
54. Ryman-Rasmussen J, Riviere J, Monteiro-Riviere N. Penetration of intact skin by quantum dots with diverse physiochemical properties. Toxicol Sci 2006, 91: 159-165.
55. Hallock M, Greenley P, DiBerardinis L, Kallin D. Potential risks of nanomaterials and how to safely handle materials of uncertain toxicity. J Chem Health Safety 2009, 16: 16-23.
56. 2 and Pt. J Nanoparticle Res 2010, 12: 83-89.
57. Rengasamy S, King WP, Eimer BC, Shaffer RE. Filtration performance of NIOSH-approved N95 and P100 filtering facepiece respirators against 4 to 30 nanometer-size nanoparticles. J Occup Environ Hyg 2008, 5: 556-564.
58. Rengasamy S, Eimer BC, Shaffer R. Comparison of Nanoparticle filtration performance of NIOSH-approved and CE-marked filtering facepiece respirators. Ann Occup Hyg 2009, 53: 117-128.